Schall Law Firm Invites KMX Investors to Participate in CarMax, Inc. Fraud Investigation – Learn How to Join

Los Angeles, CA — Investors in CarMax, Inc. have a chance to participate in a fraud investigation led by the Schall Law Firm concerning the used car giant. Allegations have surfaced suggesting that CarMax may have engaged in deceptive business practices that infringed upon federal securities laws. This probe aims to ascertain whether CarMax provided misleading financial details to its shareholders, thereby potentially manipulating the market. The Schall Law Firm, known for its specialization in securities class action lawsuits and shareholder rights litigation, announced that they are inviting investors who suffered losses to join the … Read more

MGPI Investors Invited to Spearhead Securities Fraud Class Action with Schall Law Firm

Los Angeles, CA – Investors in MGP Ingredients, Inc. now have an opportunity to lead a securities fraud lawsuit against the distilled spirits and ingredients company. The case is being assembled by The Schall Law Firm, a Los Angeles-based legal group that specializes in shareholder rights litigation. The suit targets allegations that MGP Ingredients may have provided misleading information to their shareholders. The Schall Law Firm has issued a call to action for any shareholders who suffered a loss to step forward as lead plaintiffs in this litigation. According to the firm, the class for … Read more

Robbins Geller Rudman & Dowd LLP Announces Deadline for Investors in TransMedics Securities Litigation; Allegations of Kickbacks and Unsafe Practices Surface

SAN DIEGO — A class action lawsuit has been filed against TransMedics Group, Inc., a medical technology company specializing in organ transplant therapy for patients with end-stage organ failure. The complaint, handled by Robbins Geller Rudman & Dowd LLP, involves allegations of securities fraud. Individuals who purchased or acquired TransMedics securities between February 28, 2023, and January 10, 2025, are urged to seek appointment as lead plaintiff by April 15, 2025. The suit, formally titled Jewik v. TransMedics Group, Inc., and filed in the District Court of Massachusetts, accuses TransMedics and some of its executives … Read more

Investors with Major Losses in ICON Urged to Contact Faruqi & Faruqi for Legal Options Before Imminent Deadline

New York, New York—Investors who have incurred significant financial losses exceeding $75,000 with ICON plc are being urged to get in touch directly with James (Josh) Wilson, a partner at Faruqi & Faruqi, LLP, a prominent national securities litigation firm. The firm has launched an investigation into possible claims against the clinical research organization, which is listed on NASDAQ under the symbol ICLR. The announcement comes as part of a legal action following reported substantial financial discrepancies during a specified period. Faruqi & Faruqi, with a history of recovering hundreds of millions of dollars for … Read more